GoodRx Powers Pricing for Pfizer Medications on TrumpRx Platform

GoodRx Holdings, Inc. Class A +1.99%
Pfizer Inc. -0.81%

GoodRx Holdings, Inc. Class A

GDRX

2.05

+1.99%

Pfizer Inc.

PFE

28.32

-0.81%

GoodRx Holdings Inc. announced that it is serving as a key integration partner for pharmaceutical companies offering discounted cash prices on the TrumpRx platform. At launch, GoodRx provides the integrated pricing source for over 30 of Pfizer's essential brand medications on TrumpRx. The company stated that this partnership enables pharmaceutical manufacturers to rapidly deploy and scale emerging pricing models, with additional manufacturer integrations expected in the future.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GoodRx Holdings Inc. published the original content used to generate this news brief on February 05, 2026, and is solely responsible for the information contained therein.